Trial Profile
Phase III study of rabeprazole as maintenance therapy for proton pump inhibitor-resistant gastro-oesophageal reflux disease/reflux oesophagitis in Japan
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 26 Aug 2013
Price :
$35
*
At a glance
- Drugs Rabeprazole (Primary)
- Indications Gastro-oesophageal reflux; Reflux oesophagitis
- Focus Registrational; Therapeutic Use
- 26 Aug 2013 New trial record